Neoplasms Metastasis Completed Phase 2 Trials for Docetaxel (DB01248)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01069081Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast CancerTreatment
NCT00142038Docetaxel and Capecitabine in Advanced Gastric CancerTreatment
NCT00377559Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast CancerTreatment
NCT02004769Trastuzumab Plus Docetaxel and Capecitabine For First Line Treatment of Her2-Positive Advanced Gastric CancerTreatment